• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)

6.920 -0.060 (-0.86%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,320,474
Open 6.950
Bid (Size) 6.900 (100)
Ask (Size) 7.370 (100)
Prev. Close 6.980
Today's Range 6.785 - 7.100
52wk Range 0.5500 - 8.000
Shares Outstanding 17,472,986
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call ↗
June 18, 2026
HC Wainwright initiates Relmada Therapeutics (NASDAQ: RLMD) with a Buy rating and $12 target, highlighting its bladder cancer potential. 
Via Benzinga
News headline image
Relmada Therapeutics Q1 Earnings Call Highlights ↗
May 12, 2026
Relmada Therapeutics (NASDAQ:RLMD) said it remains on track to begin its Phase 3 RESCUE registrational program for NDV-01 in mid-2026 after reporting 12-month Phase 2 data in non-muscle invasive... 
Via MarketBeat
Topics Earnings Intellectual Property

Performance

YTD
+58.4%
+58.4%
1 Month
+1.0%
+1.0%
3 Month
+8.5%
+8.5%
6 Month
+55.5%
+55.5%
1 Year
+1052.8%
+1052.8%

More News

Read More
News headline image
Relmada (RLMD) Q4 2025 Earnings Call Transcript ↗
March 19, 2026
Via The Motley Fool
Topics Earnings Economy
Relmada Therapeutics Inc (NASDAQ:RLMD) Reports Q4 2025 Earnings Miss, Stock Declines ↗
March 19, 2026
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Via Benzinga
Unusual volume stocks in Tuesday's session ↗
March 10, 2026
Via Chartmill
Top stock movements in today's session. ↗
March 09, 2026
Via Chartmill
Monday's session: top gainers and losers ↗
March 09, 2026
Via Chartmill
Gapping stocks in Monday's session ↗
March 09, 2026
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
March 09, 2026
Via Chartmill
News headline image
RLMD Stock Soars Pre-Market: Phase 2 Bladder Cancer Trial Data Impresses Investors ↗
March 09, 2026
Via Stocktwits
News headline image
Relmada Therapeutics Inc (NASDAQ:RLMD) Reports Wider-Than-Expected Q3 2025 Loss ↗
November 13, 2025
Via Chartmill
News headline image
Relmada (RLMD) Q3 2025 Earnings Call Transcript ↗
November 13, 2025
Via The Motley Fool
Topics Earnings
News headline image
A Glimpse of Relmada Therapeutics's Earnings Potential ↗
November 12, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
November 04, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
October 06, 2025
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
October 03, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 03, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
September 04, 2025
Via Benzinga
News headline image
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
September 03, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 02, 2025
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-08-29: top gainers and losers in today's session. ↗
August 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
August 29, 2025
Via Benzinga
News headline image
Top movers in Friday's session ↗
August 29, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
August 29, 2025
Via Benzinga

Frequently Asked Questions

Is Relmada Therapeutics, Inc. - Common Stock publicly traded?
Yes, Relmada Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Relmada Therapeutics, Inc. - Common Stock trade on?
Relmada Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Relmada Therapeutics, Inc. - Common Stock?
The ticker symbol for Relmada Therapeutics, Inc. - Common Stock is RLMD on the Nasdaq Stock Market
What is the current price of Relmada Therapeutics, Inc. - Common Stock?
The current price of Relmada Therapeutics, Inc. - Common Stock is 6.920
When was Relmada Therapeutics, Inc. - Common Stock last traded?
The last trade of Relmada Therapeutics, Inc. - Common Stock was at 06/30/26 04:00 PM ET
What is the market capitalization of Relmada Therapeutics, Inc. - Common Stock?
The market capitalization of Relmada Therapeutics, Inc. - Common Stock is 120.91M
How many shares of Relmada Therapeutics, Inc. - Common Stock are outstanding?
Relmada Therapeutics, Inc. - Common Stock has 121M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap